Down-regulation of Risa improves podocyte injury by enhancing autophagy in diabetic nephropathy

Abstract

Risa could inhibit autophagy by regulating the Sirt1/GSK3β axis, thereby aggravating podocyte injury in DN. Risa may serve as a therapeutic target for the treatment of DN.